Haddad syndrome is a rare genetic condition that combines congenital central hypoventilation and Hirschsprung disease. Babies with Haddad syndrome often have trouble breathing during sleep and constipation from birth. Features start in newborns and tend to be lifelong, but severity can vary. Treatment focuses on breathing support like assisted ventilation and surgery for the bowel. Outcomes depend on timely care, and many children do better with coordinated, ongoing treatment.
Overview
Haddad syndromeSymptoms
Haddad syndrome features shallow or absent breathing, especially during sleep, soon after birth. Babies often have severe constipation or blocked bowels from Hirschsprung disease, feeding trouble, blue spells, and poor temperature control. Doctors may note weak responses to carbon dioxide.
Outlook and prognosis
Many living with Haddad syndrome can do well with early, coordinated care. Ongoing breathing support and regular bowel management are common, and growth and development are closely monitored. Outcomes vary, but timely interventions often improve comfort, independence, and long‑term health.
Causes and risk factors
Haddad syndrome is caused by changes in the PHOX2B gene, usually new (de novo) and sometimes inherited, beginning before birth. Risk rises if a parent carries the variant, including mosaicism; lifestyle doesn’t cause it.
Genetic influences
Genetics play a central role in Haddad syndrome. Most cases involve inherited or new changes in the PHOX2B gene, which guides development of the autonomic nervous system and gut. Genetic testing helps confirm diagnosis, clarify inheritance risks, and inform family planning.
Diagnosis
Diagnosis of Haddad syndrome relies on recognizable clinical features and is confirmed by PHOX2B genetic testing and supportive studies, such as rectal biopsy or imaging. Genetic diagnosis of Haddad syndrome helps direct treatment planning and family counseling.
Treatment and drugs
Treatment for Haddad syndrome focuses on reliable breathing support and bowel care from infancy onward. Many need assisted ventilation (often at night), careful infection prevention, and tailored nutrition. Bowel management may include rectal irrigations, laxatives, botulinum toxin, or surgery for Hirschsprung disease.
Symptoms
In newborns and young infants, it often shows up as quiet breathing during sleep and trouble passing stool. Haddad syndrome brings together breathing control problems and a bowel blockage present from birth, so daily care may involve breathing support and bowel surgery early on. Parents often first notice early features of Haddad syndrome in the first days or weeks, such as a swollen belly, vomiting, or bluish lips during sleep. Features vary from person to person and can change over time.
In Haddad syndrome, breathing can be too slow or too shallow during sleep. Babies may not wake up despite low oxygen or rising carbon dioxide.
In more severe cases, under-breathing also happens when awake. Illness, naps, or anesthesia can make it worse.
In medical terms, this is Hirschsprung disease; in everyday life, it shows up as no first stool in the first day or two, very hard-to-pass stools, or needing help to pass gas. In Haddad syndrome, this starts at birth and continues day to day. Babies may strain, cry, or become fussy around bowel movements.
The abdomen can look tight and distended. Vomiting, sometimes green or yellow, can happen when the bowel is blocked.
How people usually first notice Haddad syndrome?
Many families first notice something is wrong soon after birth when a full-term newborn has trouble breathing on their own and needs ventilation; doctors then find absent or very low drive to breathe during sleep along with signs of Hirschsprung disease, such as a swollen belly, poor feeding, vomiting, or no passage of meconium in the first day or two. These paired features—congenital central hypoventilation and bowel blockage from missing nerve cells—are classic first signs of Haddad syndrome and often prompt urgent tests, including abdominal X‑rays, rectal biopsy, and breathing assessments. Sometimes the picture emerges over the first weeks if constipation, abdominal distension, or apnea spells during sleep become clearer, leading families and clinicians to recognize how Haddad syndrome is first noticed.
Types of Haddad syndrome
Haddad syndrome is a rare genetic condition that combines Hirschsprung disease (missing nerve cells in part of the bowel) with congenital central hypoventilation syndrome (impaired automatic breathing during sleep and sometimes when awake). Variants are mainly defined by the gene change and how extensive the bowel and breathing issues are. Clinicians often describe them in these categories: Short-segment vs. long-segment bowel involvement, presence of autonomic nervous system features, and whether a PHOX2B gene expansion is present and its size. Not everyone will experience every type.
Short-segment HSCR
The missing nerve cells affect only the rectum and sigmoid colon. Bowel symptoms start in the newborn period with constipation, tummy swelling, or delayed first stool. Breathing problems during sleep are still a core feature.
Long-segment HSCR
The aganglionosis extends higher in the colon or into the small intestine. These babies often need earlier surgery and may have more feeding and growth challenges. Sleep-related hypoventilation varies from sleep-only to sleep-and-awake impairment.
Total colonic HSCR
The entire colon lacks nerve cells. This form typically requires staged surgeries and careful nutrition support. Breathing support is still needed, especially during sleep.
CCHS sleep-only
Breathing drive is reduced mainly during sleep. Children may seem well when awake but need consistent ventilatory support overnight. Daily life often makes the differences between symptom types clearer.
CCHS sleep-and-awake
Low breathing drive occurs both asleep and awake, especially during illness or quiet wakefulness. Daytime ventilatory support, tracheostomy, or diaphragm pacing may be considered. Early symptoms of Haddad syndrome can include poor breathing after birth and severe constipation.
Autonomic features prominent
In addition to bowel and breathing issues, people may have temperature instability, reduced heart-rate variability, or fainting episodes. Eye-pupil changes, reduced sweating, or reflux can be noticeable. Loved ones may recognize certain types sooner than the person experiencing them.
PHOX2B polyalanine 20/24–20/25
A smaller polyalanine repeat expansion in the PHOX2B gene is often linked with milder breathing impairment and shorter HSCR segments. Some need ventilatory support only during sleep. Severity can still vary within families.
PHOX2B polyalanine 20/26–20/27
Larger expansions tend to correlate with more severe hypoventilation and longer HSCR segments. Daytime breathing support is more likely. Careful monitoring for autonomic symptoms is important.
PHOX2B non-polyalanine
Non-polyalanine mutations (like missense or frameshift) are often associated with severe presentations. These can include extensive HSCR and significant autonomic dysfunction. Management usually requires multidisciplinary care.
What genetics can tell you about symptoms
Some people with Haddad syndrome (congenital central hypoventilation plus Hirschsprung disease) have changes in the PHOX2B gene that blunt the brain’s automatic drive to breathe during sleep or illness. The same gene changes can disrupt gut nerve cells, causing severe constipation or intestinal blockages.
Causes and risk factors
Haddad syndrome is usually caused by a change in the PHOX2B gene that affects the nerves for breathing and the bowel. Most cases happen as a new change, but it can also be passed from a parent. Some risks are written in our DNA, passed down through families. Different types of PHOX2B changes can affect how severe Haddad syndrome is and the chance of Hirschsprung disease. There are no proven lifestyle or environmental causes, so risk mainly relates to family history and the genetic causes of Haddad syndrome.
Environmental and biological risk factors
Risk for Haddad syndrome is set early, often long before birth, and mostly reflects how the body’s nervous system develops. Doctors often group risks into internal (biological) and external (environmental). For this condition, environmental risk factors for Haddad syndrome have not been clearly identified, and most cases happen without a known outside trigger.
Risk arises from inborn differences in how the gut and breathing-control nerves form in the embryo. These biological changes are set before birth and underpin Haddad syndrome.
Older paternal age slightly increases the chance of new changes when sperm are formed. This can raise the baseline risk for some rare conditions present at birth, though the absolute risk remains very low.
No specific environmental exposures have been confirmed to increase the risk of Haddad syndrome. Studies have not shown consistent links with air pollution, common household chemicals, or routine infections during pregnancy.
Chronic conditions such as diabetes or thyroid disease can influence fetal development in general. There is no consistent evidence that these conditions specifically raise the likelihood of this syndrome.
Genetic risk factors
Haddad syndrome is driven mainly by changes in a nerve-development gene called PHOX2B. These changes can be inherited in an autosomal dominant way or arise for the first time in a child, and their exact type often influences how severe the breathing and bowel features are. People with the same risk factor can have very different experiences, and genetic testing can clarify risk before early symptoms of Haddad syndrome appear.
PHOX2B gene: Most people with Haddad syndrome have a disease-causing change in the PHOX2B gene, which guides development of the automatic nervous system. Finding this change confirms the genetic cause and helps estimate related risks like Hirschsprung disease.
Repeat size: Many cases involve an expansion of a small repeated stretch within PHOX2B (a polyalanine repeat). Larger expansions generally track with more severe hypoventilation and a higher chance of Hirschsprung disease.
Non-repeat variants: Frameshift or other non-repeat changes in PHOX2B can disrupt the gene more strongly. These variants are often linked to a higher risk of Hirschsprung disease and tumors of nerve tissue, such as neuroblastoma.
Autosomal dominant: If a parent carries a PHOX2B variant, each child has a 1-in-2 (50%) chance of inheriting it. Family members with the same variant can show different feature combinations, from isolated breathing problems to full Haddad syndrome.
De novo change: In most families, the PHOX2B change arises for the first time in the affected child. This means parents typically do not carry the variant, but genetic testing can confirm whether it is new.
Parental mosaicism: Sometimes a parent has the PHOX2B change in only a portion of their egg or sperm cells. This hidden mosaic pattern can raise the chance of having another child with Haddad syndrome even if the parent’s blood test is negative.
Modifier genes: Variants in other genes involved in gut nerve development, such as RET, EDNRB, or EDN3, can raise the chance of Hirschsprung disease when a PHOX2B change is present. These modifiers help explain why Haddad syndrome affects bowel function more in some families than others.
Variable expressivity: The same PHOX2B change can lead to different severities and combinations of features. Some relatives show classic Haddad syndrome, while others have only breathing problems without Hirschsprung disease.
Lifestyle risk factors
Lifestyle habits do not cause Haddad syndrome, but daily choices can shape breathing stability, bowel function, and complication risks. Understanding how lifestyle affects Haddad syndrome helps families prioritize routines that support ventilation and gut health. The focus is on behaviors that modify symptoms, safety, and quality of life.
Consistent use of prescribed ventilatory support during sleep and naps maintains safe oxygen and carbon dioxide levels. Skipping or shortening sessions increases hypoventilation and cardiac strain.
A fixed sleep schedule and sufficient sleep reduce periods of unmonitored hypoventilation. Elevating the head of the bed and avoiding prone sleep can help airway mechanics and monitoring accuracy.
Alcohol, opioids, benzodiazepines, and antihistamines can further depress respiratory drive. Avoiding or strictly supervising these substances reduces nocturnal hypoventilation and hospitalizations.
Regular, supervised activity can improve cardiovascular conditioning and breathing efficiency. Avoiding overexertion and using ventilatory support as prescribed during exertion helps prevent hypoxemia and arrhythmias.
Risk prevention
Haddad syndrome can’t be prevented, but many steps can lower day-to-day risks and avoid serious complications. Prevention is about lowering risk, not eliminating it completely. Recognizing early symptoms of Haddad syndrome in newborns—such as poor breathing during sleep or trouble passing stool—and acting quickly can make a big difference. Planning ahead, keeping up with check-ups, and training caregivers all help protect health over time.
If Haddad syndrome or PHOX2B changes run in the family, meet with a genetics team to discuss inheritance and testing. Options can include prenatal or preimplantation testing when planning a pregnancy.
For babies with a family history or concerning signs, monitor oxygen and carbon dioxide and watch bowel function from birth. Spotting early symptoms of Haddad syndrome allows prompt ventilation and gut care.
Use prescribed breathing support during sleep and during illnesses as directed. Consistent use helps prevent low oxygen and high carbon dioxide that can affect the brain and heart.
Keep vaccines current, including influenza and pneumococcal, and practice hand hygiene. Respiratory infections can worsen hypoventilation in Haddad syndrome.
Transmission
Haddad syndrome is not contagious—you can’t catch it from someone else. It happens because of a change in a gene that guides development of the body’s automatic (autonomic) nerves, most often in a gene called PHOX2B. In many families, this change arises for the first time in the child (a new mutation) with no previous family history.
When a parent carries the gene change, Haddad syndrome follows an autosomal dominant pattern, meaning each pregnancy has a 50% chance of inheriting it. Because some parents may carry the change in only a portion of their cells (mosaicism), genetic counseling and testing can help clarify the genetic transmission of Haddad syndrome and how Haddad syndrome is inherited in a given family.
When to test your genes
Choose genetic testing if you or your child has chronic constipation from birth, difficulty breathing during sleep, or both—especially if Hirschsprung disease plus central hypoventilation are suspected. Test sooner with a family history of Haddad syndrome or known PHOX2B variants. Results can guide breathing support, anesthesia safety, and family planning.
Diagnosis
Haddad syndrome is usually identified early because babies show a pattern of poor breathing—especially during sleep—and bowel blockage from birth. Doctors look for this combination of features and then confirm it with targeted tests. Early and accurate diagnosis can help you plan ahead with confidence.
The hallmark is central hypoventilation together with signs of bowel blockage such as delayed meconium, vomiting, or a swollen belly. Noticing both breathing and gut symptoms in a newborn raises strong suspicion for Haddad syndrome.
A small tissue sample from the rectum is examined for missing nerve cells that confirm Hirschsprung disease. This test is the gold standard for proving the bowel problem.
A blood or saliva sample is checked for changes in the PHOX2B gene, often a repeat expansion. This is the cornerstone for the genetic diagnosis of Haddad syndrome.
An overnight polysomnogram with CO2 and oxygen monitoring documents hypoventilation, especially during sleep. Results help tailor ventilatory support and confirm the breathing control problem.
Stages of Haddad syndrome
Haddad syndrome does not have defined progression stages. It is present from birth, and although the severity varies—ranging from life-long problems with automatic breathing, especially during sleep, to intestinal blockage from Hirschsprung disease—it does not follow a predictable step-by-step decline. Early symptoms of Haddad syndrome often include pauses in breathing or low oxygen in the newborn period and severe constipation or failure to pass stool, but patterns differ between children. Different tests may be suggested to help confirm the diagnosis, such as continuous oxygen and carbon dioxide monitoring, a sleep study, imaging and a rectal biopsy for Hirschsprung disease, and genetic testing of the PHOX2B gene.
Outlook and prognosis
Day to day, Haddad syndrome can mean extra monitoring in infancy and childhood, with check-ins for breathing, feeding, growth, and bowel function. Early care can make a real difference, especially when breathing support and intestinal surgery are coordinated quickly by a specialized team. Some children need a ventilator or tracheostomy for central hypoventilation, and many have surgery for Hirschsprung disease; over time, care often shifts toward fine-tuning equipment, nutrition, and infection prevention rather than constant crisis management.
Looking at the long-term picture can be helpful. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, including the specific PHOX2B gene change, how extensive the bowel involvement is, and how reliably breathing support is used during sleep and illness. Survival has improved substantially with modern ventilators, careful anesthesia planning, and early recognition of infections; some children with Haddad syndrome now reach adulthood. That said, serious complications can occur, such as severe infections, heart rhythm issues, or breathing failure during sleep, which is why consistent use of prescribed respiratory support is so important.
Many people ask, “What does this mean for my future?”, and the answer is that the trajectory varies. Early symptoms of Haddad syndrome often appear in the first days of life, but the intensity can mellow as families and care teams optimize ventilator settings, nutrition, and bowel routines. With ongoing care, many people maintain school attendance, social activities, and steady growth, though they may need extra planning for travel, sports, and surgery. Talk with your doctor about what your personal outlook might look like, including warning signs to watch for and how to plan for transitions from pediatric to adult care.
Long-term effects
People with Haddad syndrome often face health needs that change with age. Long-term effects vary widely, depending on how strongly breathing control and the gut are affected. Many families first notice early symptoms of Haddad syndrome in the newborn period, but the outlook depends more on ongoing breathing stability, growth, and nerve-related features. Over time, the long-term picture reflects both the breathing condition and the bowel condition that come with this syndrome.
Lifelong hypoventilation during sleep is typical and may also affect quiet wakefulness. This raises the risk of low oxygen and high carbon dioxide over time.
Repeated low oxygen can strain the heart and lungs. Over years, this may contribute to pulmonary hypertension and increase illness severity during infections.
People with Haddad syndrome have a higher chance of pauses or abnormal rhythms. These can lead to fainting, seizures from low oxygen, or rarely sudden events.
Even after surgery for Hirschsprung disease, long-term constipation or diarrhea can persist. Some experience episodes of enterocolitis, abdominal bloating, or challenges with continence.
How is it to live with Haddad syndrome?
Living with Haddad syndrome often means navigating complex medical routines from infancy, including assisted breathing (often ventilator support, sometimes a tracheostomy) and close monitoring of bowel function after surgery for Hirschsprung disease. Daily life can revolve around equipment checks, airway care, feeding plans, and preventing infections, with frequent appointments to adjust ventilation settings, medications, and nutritional support as a child grows. Families and caregivers shoulder a significant role—learning specialized care skills, coordinating home nursing or school accommodations, and balancing vigilance with giving a child space to play and develop. Many find that a strong care team, reliable emergency plans, and connections with other families living with rare autonomic conditions can turn a demanding routine into one that feels more predictable and hopeful.
Treatment and drugs
Haddad syndrome is treated by addressing both breathing pauses and constipation from nerve problems in the gut. Newborns and infants often need help with breathing—this can include oxygen, ventilator support, or a breathing pacemaker placed by a specialist—and surgery to remove or bypass the poorly working part of the large intestine to relieve severe constipation. Doctors sometimes recommend a combination of lifestyle changes and drugs, such as stool softeners, laxatives, and rectal irrigations alongside surgery, while ventilatory support may be needed long term during sleep or around the clock depending on severity. Genetic counseling, routine vaccines, nutrition support, and ongoing follow-up with a multidisciplinary team (pulmonology, gastroenterology, surgery, and genetics) are important to adjust care as a child grows. Finding the right therapy can take some time, so keep track of symptoms and work closely with your care team to fine-tune treatment.
Non-drug treatment
Living with Haddad syndrome usually involves day-to-day routines that support breathing, gut function, and development. Non-drug treatments often lay the foundation for safety at home, school, and during sleep. Plans are tailored by age and severity, with families trained to use equipment, spot changes, and act early; understanding early symptoms of Haddad syndrome can help you know when to seek care.
Ventilator support during sleep—through a mask or a tracheostomy—helps people with Haddad syndrome keep oxygen and carbon dioxide in a safe range. Regular sleep studies are used to adjust settings as children grow. This lowers the risk of night-time breath-holding and morning headaches.
Surgically placed wires stimulate the diaphragm to breathe. It can reduce daytime ventilator hours for some, especially during wakefulness. Not every approach works the same way.
Daily suction, humidification, and airway clearance techniques keep mucus thin. This helps prevent plugs and chest infections. Caregivers are taught safe techniques.
Pulse oximetry and, when available, capnography track oxygen and carbon dioxide in Haddad syndrome. Alarmed monitors help families act quickly during sleep or illness. Your team will show you how to record and share readings.
Your genes may have an impact on how drugs work for you
Medicines for Haddad syndrome can work differently based on gene changes that affect breathing control, autonomic signaling, and drug processing in the liver. Genetic testing may guide dose choices, timing, and monitoring to improve benefit and reduce side effects.
Pharmacological treatments
Medicines in Haddad syndrome mostly play a supporting role. They can ease breathing drive a bit, help bowels move, and treat infections, but they do not replace assisted ventilation or surgery for Hirschsprung disease. If you’re weighing options, ask your doctor why a specific drug was recommended for you. Some choices are off‑label and used cautiously, especially in babies and young children.
May lightly stimulate breathing drive in some infants. It is not a substitute for ventilation and its benefits in Haddad syndrome are limited. Side effects can include fast heart rate and irritability.
Can stimulate the respiratory center but has a narrow safety window. Blood levels must be monitored to avoid side effects like vomiting, tremor, or heart rhythm issues.
Sometimes tried to increase breathing by changing blood acidity. Evidence for benefit in Haddad syndrome is limited, so it is considered only in select cases with close monitoring.
A hormone-based respiratory stimulant occasionally used in older patients. It has modest effects at best and is not recommended for infants or as primary therapy.
Genetic influences
In most people, Haddad syndrome traces back to a change in a single gene called PHOX2B, which helps form the nerves that automatically control breathing and how the bowel moves. It’s natural to ask whether family history plays a role. Many cases are not inherited and happen for the first time in a child, but the condition can also be passed down in a dominant way—so if a parent carries the change, each child has up to a 50% chance of inheriting it. Sometimes a parent has very mild signs or carries the change in only some cells (mosaicism), which can make the family history look clear even when a genetic cause is there. Different PHOX2B changes are linked with different levels of severity, and even within the same family the symptoms of Haddad syndrome can vary. Genetic testing for Haddad syndrome typically looks for PHOX2B changes, and genetic counseling can help you understand results and plan for future pregnancies.
Is Haddad syndrome genetic?
Genetics play a central role in Haddad syndrome. Most cases involve inherited or new changes in the PHOX2B gene, which guides development of the autonomic nervous system and gut. Genetic testing helps confirm diagnosis, clarify inheritance risks, and inform family planning.
Pharmacogenetics—how genetics influence drug effects
In Haddad syndrome, the specific change in a gene called PHOX2B—important for breathing control and the gut’s nerve network—can shape the care plan. Larger or more complex PHOX2B changes are linked with more severe breathing problems, which may steer choices between noninvasive ventilation, tracheostomy, or diaphragm pacing, and with how much of the bowel needs surgery. Because many medicines can slow breathing, people with Haddad syndrome are managed carefully around opioids, certain sleep or anxiety medicines, and some anesthetics; when pain relief is needed, pharmacogenetic testing for drug‑metabolizing enzymes (such as CYP2D6) can guide whether drugs like codeine or tramadol are likely to be safe or effective. For bowel management after Hirschsprung surgery, stool softeners and medicines that help movement are tailored to each person; pharmacogenetics plays a smaller role here, but the PHOX2B result alerts teams to autonomic sensitivities that can affect gut motility. Alongside medical history and other factors, genetic testing can help doctors personalize anesthesia plans and post‑operative pain control. Genetics is one piece of the puzzle; age, weight, other health conditions, and the rest of your medication list also shape drug response in Haddad syndrome, so pharmacogenetic testing for Haddad syndrome adds to, rather than replaces, careful clinical monitoring.
Interactions with other conditions
Colds, flu, or chest infections can make the breathing problems in Haddad syndrome much worse, sometimes tipping someone who usually manages during the day into needing more ventilatory support at home or in the hospital. Sedating medicines, including some pain relievers and anesthesia, can further slow breathing, so procedures and new prescriptions usually need extra planning to stay safe. Heart rhythm issues and blood pressure swings can occur alongside the autonomic nerve changes in Haddad syndrome, and over time, chronic underventilation can strain the lungs and heart, raising the risk of pulmonary hypertension. Some conditions share “underlying mechanisms,” such as changes in neural crest development and PHOX2B, which is why Haddad syndrome can occur with Hirschsprung-related bowel problems and, less often, nerve‑tissue tumors like neuroblastoma. Gut infections or severe constipation can lead to dehydration and sepsis risk in people with Haddad syndrome, and these stresses often worsen breathing control, creating a cycle that needs prompt care. Because early symptoms of Haddad syndrome can overlap with other newborn issues, teams often coordinate across pulmonology, gastroenterology, cardiology, and oncology to watch for overlapping problems and to adjust care as health needs change over time.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described newborns who struggled to pass stool and later had pauses in breathing during sleep. Families and communities once noticed patterns: a baby needing surgery for a blocked intestine, then months later being diagnosed with sleep-related breathing problems. Today, we know this combined picture as Haddad syndrome.
First described in the medical literature as a link between Hirschsprung disease (a missing segment of gut nerves that causes severe constipation and intestinal blockage) and congenital central hypoventilation syndrome (a condition where automatic breathing during sleep is too shallow), reports from the late 20th century pulled together earlier, separate observations. Before that, the gut symptoms and the breathing symptoms were often treated as unrelated. A surgeon might record a newborn with a distended abdomen who needed part of the large intestine removed. A pulmonologist years later might note a child whose oxygen dipped at night and who needed assisted ventilation. Only when case series accumulated did clinicians recognize a consistent pattern in some children: both conditions occurring in the same person.
From these first observations, researchers looked for a unifying cause. Advances in genetics in the 1990s and early 2000s pointed to changes in the PHOX2B gene, which helps guide the development of the autonomic nervous system—the network that oversees “automatic” tasks like gut movement and breathing. This discovery explained why the bowel and breathing control could both be affected in Haddad syndrome. It also clarified that the condition sits within a broader group of disorders tied to the same gene, helping doctors refine diagnosis and counseling.
Over time, descriptions became more precise. Clinicians learned that not everyone with Hirschsprung disease has hypoventilation, and not everyone with congenital hypoventilation has Hirschsprung disease. But in a subset, the two occur together, and that is what defines Haddad syndrome. Studies also documented variation: the length of bowel affected can range from a short segment to the entire colon, and the severity of breathing problems can differ, often showing up most clearly during sleep in the newborn period.
In recent decades, knowledge has built on a long tradition of observation. Shared registries, neonatal intensive care advances, and long-term follow-up helped shape care pathways—early bowel surgery when needed, careful sleep studies, and timely respiratory support. Knowing the condition’s history helps explain why a child might see multiple specialists early on and why genetic testing plays a central role today. As understanding grew, so did survival and quality of life for many living with Haddad syndrome, with care plans tailored to the individual and adjusted as children grow.